Clinical Trial Update: A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing trastuzumab emtansine plus pertuzumab against chemotherapy plus trastuzumab and pertuzumab in HER2-positive breast cancer has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Neoplasms

Drugs mentioned

• Chemotherapy (chemotherapy)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2017-06-08